Oxidative Stress in Amyotrophic Lateral Sclerosis: Pathophysiology and Opportunities for Pharmacological Intervention

المؤلفون المشاركون

Saso, Luciano
Cunha-Oliveira, Teresa
Montezinho, Liliana
Mendes, Catarina
Firuzi, Omidreza
Oliveira, Paulo J.
Silva, Filomena S. G.

المصدر

Oxidative Medicine and Cellular Longevity

العدد

المجلد 2020، العدد 2020 (31 ديسمبر/كانون الأول 2020)، ص ص. 1-29، 29ص.

الناشر

Hindawi Publishing Corporation

تاريخ النشر

2020-11-16

دولة النشر

مصر

عدد الصفحات

29

التخصصات الرئيسية

الأحياء

الملخص EN

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease or Charcot disease, is a fatal neurodegenerative disease that affects motor neurons (MNs) and leads to death within 2–5 years of diagnosis, without any effective therapy available.

Although the pathological mechanisms leading to ALS are still unknown, a wealth of evidence indicates that an excessive reactive oxygen species (ROS) production associated with an inefficient antioxidant defense represents an important pathological feature in ALS.

Substantial evidence indicates that oxidative stress (OS) is implicated in the loss of MNs and in mitochondrial dysfunction, contributing decisively to neurodegeneration in ALS.

Although the modulation of OS represents a promising approach to protect MNs from degeneration, the fact that several antioxidants with beneficial effects in animal models failed to show any therapeutic benefit in patients raises several questions that should be analyzed.

Using specific queries for literature search on PubMed, we review here the role of OS-related mechanisms in ALS, including the involvement of altered mitochondrial function with repercussions in neurodegeneration.

We also describe antioxidant compounds that have been mostly tested in preclinical and clinical trials of ALS, also describing their respective mechanisms of action.

While the description of OS mechanism in the different mutations identified in ALS has as principal objective to clarify the contribution of OS in ALS, the description of positive and negative outcomes for each antioxidant is aimed at paving the way for novel opportunities for intervention.

In conclusion, although antioxidant strategies represent a very promising approach to slow the progression of the disease, it is of utmost need to invest on the characterization of OS profiles representative of each subtype of patient, in order to develop personalized therapies, allowing to understand the characteristics of antioxidants that have beneficial effects on different subtypes of patients.

نمط استشهاد جمعية علماء النفس الأمريكية (APA)

Cunha-Oliveira, Teresa& Montezinho, Liliana& Mendes, Catarina& Firuzi, Omidreza& Saso, Luciano& Oliveira, Paulo J.…[et al.]. 2020. Oxidative Stress in Amyotrophic Lateral Sclerosis: Pathophysiology and Opportunities for Pharmacological Intervention. Oxidative Medicine and Cellular Longevity،Vol. 2020, no. 2020, pp.1-29.
https://search.emarefa.net/detail/BIM-1204697

نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)

Cunha-Oliveira, Teresa…[et al.]. Oxidative Stress in Amyotrophic Lateral Sclerosis: Pathophysiology and Opportunities for Pharmacological Intervention. Oxidative Medicine and Cellular Longevity No. 2020 (2020), pp.1-29.
https://search.emarefa.net/detail/BIM-1204697

نمط استشهاد الجمعية الطبية الأمريكية (AMA)

Cunha-Oliveira, Teresa& Montezinho, Liliana& Mendes, Catarina& Firuzi, Omidreza& Saso, Luciano& Oliveira, Paulo J.…[et al.]. Oxidative Stress in Amyotrophic Lateral Sclerosis: Pathophysiology and Opportunities for Pharmacological Intervention. Oxidative Medicine and Cellular Longevity. 2020. Vol. 2020, no. 2020, pp.1-29.
https://search.emarefa.net/detail/BIM-1204697

نوع البيانات

مقالات

لغة النص

الإنجليزية

الملاحظات

Includes bibliographical references

رقم السجل

BIM-1204697